|
Article:
New Treatments That Offer Increased Hope For Osteoporosis Patients by: Janet Vasquez For a time, hormone replacement therapy (the administration of estrogen either alone or in combination with other hormones) served as the preferred treatment for post-menopausal women hoping to reduce the progression of osteoporosis, a debilitating and inevitable bone-thinning disorder. Yet the latest findings from the prematurely halted Women's Health Initiative (WHI) study on hormone replacement therapy alarmed many women. The study concluded that an estrogen and progestin combination used by thousands increased the risk of breast cancer, blood clots, heart attacks, and strokes when taken over a long period of time. Osteoporosis is drastically accelerated during menopause and is the third leading cause of death of women over 70. By age '55
|
